WINDTREE THERAPEUTICS INC (46)
Browse by Contract Category
Contracts
-
Form of Inducement Letter
(Filed With SEC on January 26, 2023)
-
Form of New Warrant
(Filed With SEC on January 26, 2023)
-
Amended and Restated License, Development and Commercialization Agreement, by and among Lees Pharmaceutical (HK) Ltd., Zhaoke Pharmaceutical (Hefei) Co. Ltd., and Windtree...
(Filed With SEC on November 14, 2022)
-
Employment Agreement by and between Windtree and Diane Carman, dated as of July 1, 2021
(Filed With SEC on March 31, 2022)
-
Agreement for Scientific Collaboration between Universita degli Studi di Milano-Bicocca and CVie Therapeutics Ltd, a wholly-owned subsidiary of the Registrant, dated March 19, 2021
(Filed With SEC on May 13, 2021)
-
Description of Securities
(Filed With SEC on March 29, 2021)
-
Form of Warrant Agency Agreement
(Filed With SEC on March 24, 2021)
-
Form of Warrant
(Filed With SEC on March 24, 2021)
-
Underwriting Agreement, dated March 23, 2021, by and among the Company and Oppenheimer & Co. Inc., as representative for the several underwriters named therein
(Filed With SEC on March 24, 2021)
-
2020 Equity Incentive Plan
(Filed With SEC on December 31, 2020)
-
Amended and Restated Supply Agreement, dated as of December 3, 2004, by and between Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) and Laboratorios Del Dr....
(Filed With SEC on November 16, 2020)
-
Collaboration Agreement dated as of October 10, 2014, by and between Battelle Memorial Institute and Discovery Laboratories, Inc. (predecessor-in-interest to Windtree)
(Filed With SEC on November 16, 2020)
-
Project Financing Agreement, dated August 12, 2020, by and between Windtree and Lees Pharmaceutical (HK) Ltd
(Filed With SEC on November 16, 2020)
-
Amended and Restated Sublicense and Collaboration Agreement, dated December 3, 2004, by and between Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) and...
(Filed With SEC on November 16, 2020)
-
Separation Agreement by and between Windtree and John A. Tattory, dated as of July 29, 2020
(Filed With SEC on August 14, 2020)
-
Employment Agreement by and between the Company and John Hamill dated as of July 20, 2020
(Filed With SEC on July 23, 2020)
-
Form of Warrant Agency Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company
(Filed With SEC on May 22, 2020)
-
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to the Registration Statement on Form S-1, filed on January 27, 2020, as amended
(Filed With SEC on May 22, 2020)
-
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1
(Filed With SEC on May 19, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on May 19, 2020)
-
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1
(Filed With SEC on May 14, 2020)
-
Form of Series I Amendment dated May 6, 2020
(Filed With SEC on May 7, 2020)
-
Loan Agreement dated March 17, 2020, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd
(Filed With SEC on May 6, 2020)
-
Binding Term Sheet dated March 18, 2020, between Windtree and Lees Pharmaceutical (HK) LTD
(Filed With SEC on May 6, 2020)
-
Form of Series I Warrant Amendment dated May 6, 2020 to the Series I Warrant dated December 6, 2019
(Filed With SEC on May 6, 2020)
-
Form of Warrant Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company
(Filed With SEC on May 6, 2020)
-
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1
(Filed With SEC on May 6, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on May 6, 2020)
-
Amendment No. 1 to Payment Restructuring Agreement effective December 7, 2018, between Windtree and Battelle Memorial Institute
(Filed With SEC on May 6, 2020)
-
Form of Series F Warrant Amendment dated April 24, 2020
(Filed With SEC on April 29, 2020)
-
Note dated April 20, 2020, between Windtree Therapeutics, Inc. and Newtek Small Business Finance, LLC
(Filed With SEC on April 24, 2020)
-
Description of Securities
(Filed With SEC on April 3, 2020)
-
Form of Non-Employee Director Option Agreement under Windtrees 2011 Long-Term Incentive Plan
(Filed With SEC on April 3, 2020)
-
Amendment to No. 1 dated February 20, 2020 to the Securities Purchase Agreement dated December 6, 2019 by and among Windtree and the purchasers party thereto
(Filed With SEC on April 3, 2020)
-
Employment Agreement dated March 1, 2020, between Windtree and Eric Curtis
(Filed With SEC on April 3, 2020)
-
Form of Registration Rights Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto
(Filed With SEC on December 9, 2019)
-
Form of Securities Purchase Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto
(Filed With SEC on December 9, 2019)
-
Form of Series I Warrant
(Filed With SEC on December 9, 2019)
-
Loan Agreement
(Filed With SEC on October 28, 2019)
-
Shareholder Loan Agreement dated April 24, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics
(Filed With SEC on April 16, 2019)
-
Loan Agreement dated October 25, 2018, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd
(Filed With SEC on April 16, 2019)
-
Form of Indemnification Agreement between Windtree and certain named directors
(Filed With SEC on April 16, 2019)
-
Shareholder Loan Agreement dated September 20, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics
(Filed With SEC on April 16, 2019)
-
Shareholder Loan Agreement dated October 26, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics
(Filed With SEC on April 16, 2019)
-
Shareholder Loan Agreement dated November 16, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics
(Filed With SEC on April 16, 2019)
-
Form of Series E Warrant dated December 11, 2018
(Filed With SEC on April 16, 2019)